Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
New to Comunitee?

or Sign Up with Email



FEB 06, 2013 - Yahoo! News

A Must Read - Share

Biogen pays Elan $3.25 billion to take over MS drug

DUBLIN (Reuters) - Biogen Idec is to take full ownership of blockbuster multiple sclerosis drug Tysabri after agreeing to pay Irish partner Elan $3.25 billion plus future royalties on sales of the drug. Irish drugmaker Elan, which has co-marketed the drug with the larger U.S. company for 12 years, said it would receive a royalty of 12 percent of Tysabri global net sales for the first 12 months after the restructuring closes. ...

Tags: Biogen pays Elan $3.25 billion to take over MS drug,  Multiple Sclerosis Latest News